$0.097
-0.010 (-10.19%)收盘时
- High
- 0.105
- Open
- 0.090
- VWAP
- 0.10
- Vol
- 29.61M
- Mkt Cap
- 29.31M
- Low
- 0.085
- Amount
- 2.83M
- EV/EBITDA, TTM
- -6.64
Cutera, Inc. develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured skincare products and secret systems and consumables. Its system platforms include AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo. The Company’s Cutera Core segment consists of the Company’s systems, consumables, skincare, and service businesses. The Cutera Core segment develops, distributes and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The Company’s AviClear segment consists of the AviClear business. The Company’s acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. Its products include CUTERA, ACUTIP 500, AVITM, AVI360, AVIANALYTICSTM, AVICARE COOLGLIDE, and more.
Analyst Ratings (4)
Piper Sandler
$1
2024-08-09
Piper Sandler
2024-08-09
目标价
$1
Stephens & Co.
$5
2024-08-09
Stephens & Co.
2024-08-09
目标价
$5
Stephens & Co.
$10
2024-06-25
Stephens & Co.
2024-06-25
目标价
$10
Piper Sandler
$3
2024-06-21
Piper Sandler
2024-06-21
目标价
$3
William Blair
—
2024-03-22
William Blair
2024-03-22
目标价
—
估值指标
事件时间线
资讯
9.005-01NewsfilterCutera® Successfully Completes Restructuring Transaction and Moves Forward with Enhanced Capital Structure
4.503-11BenzingaUS Stocks Mixed; Kohl's Shares Plunge After Q4 Results
9.503-11BenzingaWhy Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
7.003-11NASDAQ.COMCutera Announces Voluntary Delisting From Nasdaq
- 2.003-10Newsfilter
Cutera Announces Voluntarily Delisting from Nasdaq
CUTR FAQ — answered by Alphio AI
Cutera, Inc. develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured skincare products and secret systems and consumables. Its system platforms include AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo. The Company’s Cutera Core segment consists of the Company’s systems, consumables, skincare, and service businesses. The Cutera Core segment develops, distributes and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The Company’s AviClear segment consists of the AviClear business. The Company’s acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. Its products include CUTERA, ACUTIP 500, AVITM, AVI360, AVIANALYTICSTM, AVICARE COOLGLIDE, and more. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).
4 analysts cover CUTR: 3 rate it Buy, 1 Hold and 0 Sell.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。